Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1958-1961

  Oshika, Y ^a   Nakamura, M ^a   Abe, Y ^a   Fukuchi, Y ^b   Yoshimura, M ^b   Itoh, M ^b   Ohnishi, Y ^b   Tokunaga, T ^a   Fukushima, Y ^a   Hatanaka, H ^a   Kijima, H ^a   Yamazaki, H ^a   Tamaoki, N ^a   Ueyama, Y ^a,b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

GM CSF; Non small cell lung cancer; Transgenic mouse; Xenograft

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER SURVIVAL; CANCER TRANSPLANTATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROGNOSIS; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032213568     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00236-6     Document Type: Article

References (15)

1. 1. Vellenga E, Uyl-de Groot CA, Wit R de, et al. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. J Clin Oncol 1996, 14, 619-627.
2. 2. Estrov Z, Talpaz M, Ku S, et al. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. Leukemia 1996, 10, 1534-1543.
3. 3. Baldwin GC, Gasson JC, Kaufman SE, et al. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989, 73, 1033-1037.
4. 4. Young MR, Charboneau S, Lozano Y, Djordjevic A, Young ME. Activation of the protein kinase A signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer 1994, 56, 446-451.
5. 5. Thacker JD, Dedhar S, Hogge DE. The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cells in vitro and in vivo. Int J Cancer 1994, 56, 236-243.
6. 6. Miyakawa Y, Hukuchi Y, Ito M, et al. Establishment of human granulocyte-macrophage colony stimulating factor producing transgenic SCID mice. Br J Haematol 1996, 95, 437-442.
7. 7. Workman P, Balmain A, Hickman JA, et al. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 1988, 58, 109-113.
8. 8. Wheeler J, Robertson H, Morley AR, Appleton DR. Antiglomerular basement membrane glomerulonephritis (anti-GBM GN) in the mouse: BrdU-labelling indices and histological damage. Int J Exp Path 1993, 74, 9-19.
9. 9. Sawyers CL, Golde DW, Quan S, Nimer SD. Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. Cancer 1991, 69, 1342-1346.
10. 10. Rokhilin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 1996, 16, 557-563.
11. 11. Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989, 73, 80-83.
12. 12. McCowage GB, White L, Carpenter P, et al. Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from Australia and New Zealand Children's Cancer Study Group. Med Pediatr Oncol 1997, 29, 108-114.
13. 13. Pujol JL, Douillard JY, Riviere A, et al. Dose-intensity of four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. J Clin Oncol 1997, 15, 2082-2089.
14. 14. Luikart SD, Herndon JE II, Hollis DR, et al. Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832). Am J Clin Oncol 1997, 20, 24-30.
15. 15. Ragnhammer P. Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors. Med Oncol 1996, 13, 167-176.